Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01765036
What this trial is testing

Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Société Française d'Endoscopie Digestive 100
Testing effectiveness (Phase 2)Ended earlyNCT05360264
What this trial is testing

TailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma Recurrent
Luca Cardone 7
Not applicableStudy completedNCT07224802
What this trial is testing

Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
City of Hope Medical Center 372
Not applicableActive Not RecruitingNCT04452357
What this trial is testing

Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT00947167
What this trial is testing

A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorsAdrenal Gland Tumors+3 more
Pamela L. Kunz 4
Testing effectiveness (Phase 2)Looking for participantsNCT05272709
What this trial is testing

TT-702 in Patients With Advanced Solid Tumours.

Who this might be right for
Advanced Solid Tumors
Cancer Research UK 60
Testing effectiveness (Phase 2)Study completedNCT01971034
What this trial is testing

Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.

Who this might be right for
Pancreatic Adenocarcinoma Advanced or Metastatic
Instituto do Cancer do Estado de São Paulo 41
Not applicableNot Yet RecruitingNCT06615830
What this trial is testing

Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.

Who this might be right for
Pancreas NeoplasmsPancreatic NeoplasmsPancreatic Cancer Metastatic+1 more
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME 185
Not applicableStudy completedNCT03273374
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Gangnam Severance Hospital 42
Not applicableStudy completedNCT00495924
What this trial is testing

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinomaNeoplasm Circulating Cells+2 more
KU Leuven 100
Not applicableUnknownNCT03673423
What this trial is testing

Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Ospedale San Raffaele 138
Early research (Phase 1)WithdrawnNCT06707896
What this trial is testing

TCR1020-CD8 T Cells in KRAS-mutated Cancers

Who this might be right for
Metastatic Pancreatic AdenocarcinomaColorectal Cancer
University of Pennsylvania
Large-scale testing (Phase 3)UnknownNCT00088660
What this trial is testing

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

Who this might be right for
Pancreatic Cancer
Therion Biologics Corporation 250
Testing effectiveness (Phase 2)Study completedNCT00053924
What this trial is testing

Perifosine in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Looking for participantsNCT06850623
What this trial is testing

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
EXACT Therapeutics AS 25
Large-scale testing (Phase 3)Looking for participantsNCT07155525
What this trial is testing

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

Who this might be right for
Pancreatic CancerPeriampullary CancerDuodenal Cancer+4 more
Minia University 194
Not applicableActive Not RecruitingNCT04395469
What this trial is testing

FAZA PET/MRI Pancreas

Who this might be right for
Pancreatic Adenocarcinoma Non-resectableLocally Advanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer
University Health Network, Toronto 20
Not applicableStudy completedNCT03644173
What this trial is testing

Personal Resilience Empowerment Program Study

Who this might be right for
Lung CancerCholangiocarcinomaPancreatic Cancer+1 more
Hackensack Meridian Health 37
Testing effectiveness (Phase 2)UnknownNCT02959151
What this trial is testing

Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

Who this might be right for
Carcinoma, HepatocellularPancreatic Cancer MetastaticColorectal Cancer Metastatic
Shanghai GeneChem Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT01677988
What this trial is testing

Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma

Who this might be right for
Adenocarcinoma of Head of Pancreas
Medical University of South Carolina 3
Next Page